ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Spondyloarthropathies"

  • Abstract Number: 1516 • ACR Convergence 2022

    How Disease Activity Can Affect Workability in Spondyloarthropaties: A Monocentric Cohort Analysis

    Federico Fattorini1, Cosimo Cigolini2, Gabriele Marchetti3, Andrea Delle Sedie4, Linda Carli5 and Marta Mosca5, 1Rheumatology Unit, University of Pisa, Pisa, Italy, 2Rheumatology Unit, University of Pisa, Pisa, Toscana, Italy, 3University of Pisa, Pisa, Toscana, Italy, 4University of Pisa, Pisa, Pisa, Italy, 5Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, PISA, Italy

    Background/Purpose: Spondyloarthropathies (SpA) may compromise the working ability (WA) of patients, often affected by the disease during their productive life. The Work Productivity and Activity…
  • Abstract Number: 2258 • ACR Convergence 2022

    Relative Frequencies of the Spectrum of MRI Lesions in the Sacroiliac Joints of Healthy Individuals and Patients with Non-Specific Back Pain: What Is the Impact of Increasing Age?

    Ulrich Weber1, Susanne Pedersen2, Mikkel Østergaard3, Pedro Machado4, Xenofon Baraliakos5, Robert G Lambert6 and Walter P Maksymowych7, 1Practice Buchsbaum Schaffhausen, Schaffhausen, Switzerland, 2Rigshospitalet, København, Denmark, 3Rigshospitalet, University of Copenhagen, Glostrup, Denmark, 4University College London, London, United Kingdom, 5Rheumazentrum Ruhrgebiet Herne, Herne, Germany, 6University of Alberta, Edmonton, AB, Canada, 7Department of Medicine, University of Alberta, Edmonton, AB, Canada

    Background/Purpose: Previous studies of patients with axial spondyloarthritis (axSpA) have demonstrated that certain MRI structural lesions in the sacroiliac joints (SIJ), notably erosions, has high…
  • Abstract Number: 0250 • ACR Convergence 2021

    Is There a Need for a New Classification Criteria in Juvenile Spondyloarthritis?

    Maria Martha Katsicas1, Maria Cecilia Bertinotti2 and Maria Giselle Villarreal2, 1Hospital de Pediatria J.P Garrahan, Buenos Aires, Argentina, 2Garrahan, Buenos Aires, Argentina

    Background/Purpose: Juvenile SpA (JSpA) involve enthesitis related arthritis (ERA), juvenile psoriatic arthritis and undifferentiated arthritis (UA) according to the ILAR criteria. Two different patterns have…
  • Abstract Number: 0932 • ACR Convergence 2021

    Sequential Treatment in Axial Spondyloarthritis – Real World Data from a Network of German Rheumatologists

    Stefan Kleinert1, Peter Bartz-Bazzanella2, Cay Von der Decken3, Kirsten Karberg4, Florian Schuch5, Georg Gauler6, Patrick Wurth7, Susanna Späthling-Mestekemper8, Christoph Kuhn9, Fabian Proft10, Denis Poddubnyy11, Mathias Englbrecht12 and Wolfgang Vorbrüggen13, 1Praxisgemeinschaft Rheumatologie - Nephrologie (PGRN), Erlangen, Germany, 2Rhein-Maas Klinikum, Wuerselen, Germany, 3Klinik für Internistische Rheumatologie, Rhein-Maas-Klinikum, Würselen, Germany, 4Praxis für Rheumatologie und Innere Medizin, Berlin, Germany, Berlin, Germany, 5Praxisgemeinschaft Rheumatologie-Nephrologie, Erlangen, Germany, 6rheumapraxis, Osnabrck, Germany, 7Rheumatologische Schwerpunktpraxis, Osnabrück, Germany, 8Rheumapraxis München, München, Germany, 9Praxis für Rheumatologie, Karlsruhe, Germany, Karlsruhe, Germany, 10Charité University Medicine Berlin, Berlin, Germany, 11Department of Rheumatology, Charité – Universitätsmedizin, Berlin, Germany, 12Freelance Healthcare Data Scientist, Eckental, Germany., Eckental, Germany, 13Verein zur Förderung der Rheumatologie e.V., Würselen, Germany

    Background/Purpose: Increasing immunmodulatory treatment options are available for axial spondyloarthritis. Little is known about sequential treatment in clinical routine.Methods: The pseudonymized RHADAR database (Kleinert, S.…
  • Abstract Number: 0285 • ACR Convergence 2021

    Risk of Cardiovascular Disease in Newly Diagnosed Rheumatoid Arthritis: A Current Risk Assessment

    Reinder Raadsen1, Romy Hansildaar1, Maaike Heslinga2, Arno van Kuijk1 and Michael Nurmohamed3, 1Reade, Amsterdam, Netherlands, 2Amsterdam University Medical Center, location VUmc, Amsterdam, Netherlands, 3Reade and Amsterdam University Medical Center, location VUmc, Amsterdam, Netherlands

    Background/Purpose: Patients with rheumatoid arthritis (RA) are known to have an increased risk of developing, mainly ischemic cardiovascular diseases (CVD). This is partly explained by…
  • Abstract Number: 0937 • ACR Convergence 2021

    Evaluation of the Safety of Vedolizumab in Combination with Other Immunosuppression Biological Therapy in Patients with Inflammatory Bowel Disease

    Gino Chesini1, Elizabeth Parrott1, Lauren Fox1, Jenna Beatty1, Cassandra Effken1, Na Yu1, Florence Hosseini-Aslinia1 and Megan Krause2, 1University of Kansas Medical Center, Kansas City, KS, 2University of Kansas, Kansas City, KS

    Background/Purpose: Inflammatory bowel disease (IBD) causes a wide range of symptomology frequently leading to co-management of disease activity between gastroenterologist and rheumatologists. Recently in efforts…
  • Abstract Number: 0369 • ACR Convergence 2021

    High Frequency of Complications in Axial Spondyloarthropathy Pregnancies: Emerging Data from the Ankylosing Spondylitis Registry of Ireland

    Sinead Maguire1, Phil Gallagher2 and Finbar (Barry) O'Shea1, 1St James's Hospital, Dublin, Ireland, 2St Vincent's Hospital, Dublin, Ireland

    Background/Purpose: National registries are excellent sources of data to allow analysis of inflammatory arthritis such as axial spondyloarthropathy (axSpA). Our understanding of axSpA has evolved…
  • Abstract Number: 0945 • ACR Convergence 2021

    A Single-cell Atlas of Human Synovial Endothelial Cells in Inflammatory Arthritis

    Sam Edalat1, Reto Gerber2, Miranda Houtman1, Raphael Micheroli3, Kristina Buerki1, Nadja Izanc1, Blaz Burja4, Tadeja Kuret5, Snežna Sodin-Šemrl5, Adrian Ciurea3, Oliver Distler3, Caroline Ospelt1, Chantal Pauli6, Mark Robinson7 and Mojca Frank-Bertoncelj3, 1Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland, 2Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, University of Zurich and Department of Molecular Life Sciences and SIB Swiss Institute of Bioinformatics, University of Zurich, Zurich, Switzerland, 3Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich/University of Zurich, Zurich, Switzerland, 4Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, University of Zurich and Department of Rheumatology, University Medical Centre Ljubljana, Zurich, Switzerland, 5Department of Rheumatology, University Medical Centre Ljubljana, Ljubljana, Slovenia, 6Department of Pathology, University Hospital Zurich, University of Zurich, Zurich, Switzerland, 7Department of Molecular Life Sciences and SIB Swiss Institute of Bioinformatics, University of Zurich, Zurich, Switzerland

    Background/Purpose: Dysregulated endothelial cell (EC) function and altered (lympho)angiogenesis crucially contribute to synovial pathology in inflammatory arthritis. Additionally, endothelium plays a key role in the…
  • Abstract Number: 0380 • ACR Convergence 2021

    Sick Leave and Its Predictors in Early Axial Spondyloarthritis: The Role of Clinical and Socioeconomic Factors. Five-year Data from the DESIR Cohort

    Elena Nikiphorou1, Annelies Boonen2, PEDRO CARVALHO3, Bruno Fautrel4, Pascal Richette5, Pedro Machado6, Désirée van der Heijde7, Robert Landewé8 and Sofia Ramiro1, 1Leiden University Medical Center, Leiden, Netherlands, 2Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Centre+ (MUMC+), Maastricht, Limburg, Netherlands, 3hospital de Faro, LISBON, Portugal, 4Pitié Salpêtrière Hospital, APHP, Sorbonne Université, Paris, France, 5Lariboisiere Hospital, Paris, France, 6Centre for Rheumatology & Department of Neuromuscular Diseases, University College London, London, United Kingdom, 7Department of Rheumatology, Leiden University Medical Center, Meerssen, Netherlands, 8Amsterdam Rheumatology & Clinical Immunology Center, Amsterdam, Netherlands; Zuyderland MC, Heerlen, Netherlands

    Background/Purpose: Sick leave (SL) represents an often poorly studied adverse work outcome especially in early axSpA, with speculation around the potential role of clinical and…
  • Abstract Number: 1115 • ACR Convergence 2021

    Uveitis and Inflammatory Bowel Disease: Study of 1449 Patients from a Single University Center

    Lara Sánchez-Bilbao1, María José García-García1, David Martinez-Lopez1, Iñigo Gonzalez-Mazon2, Montserrat Rivero-Tirado1, Beatriz Castro1, Javier Crespo1, Miguel Ángel gonzalez-Gay3 and Ricardo Blanco4, 1Hospital Universitario Marqués de Valdecilla, Santander, Spain, 2H. U. Marques de Valdecilla, Santander, Spain, 3Research group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, IDIVAL, Division of Rheumatology, Hospital Universitario Marqués de Valdecilla; School of Medicine, Universidad de Cantabria, Santander, Spain. Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa, 4Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain

    Background/Purpose: Inflammatory bowel disease (IBD), which includes Crohn's disease (CD), and Ulcerative colitis (UC) are related to Spondyloarthritis (SpA). Ocular manifestations (OM) are well-stablished in…
  • Abstract Number: 0382 • ACR Convergence 2021

    Six-year Results from the Esperanza Cohort: Evaluation of Clinical Features, Disease Activity Measures and Treatment Aspects in Axial and Peripheral Early Spondyloarthritis

    Carolina Tornero1, Victoria Navarro-Compán2, raquel almodovar3, Cristina fernández-Carballido4, Azucena Hernández5, Beatriz Joven-Ibáñez6, Xavier Juanola7, M.Lourdes Ladehesa-Pineda8, José Ramón maneiro9, Antoni Juan Mas10, carlos Montilla11, Manuel J Moreno12, Mireia moreno13, José A. pinto14, juan Carlos Quevedo15, José Rosas16, Teresa Ruiz17, Jesús Sanz18 and Eugenio De Miguel19, 1University Hospital La Paz, Madrid, Spain, 2Rheumatology service, Hospital Universitario La Paz-IdiPaz, Madrid, Spain, 3Hospital Universitario Fundación de Alcorcón, Madrid, Spain, 4H. San Juan, Alicante, Alicante, Spain, 5Hospital Virgen de la Salud, Toledo, Spain, 6University Hospital 12 de Octubre, Madrid, Spain, 7Hospital Universitari de Bellvitge, Barcelona, Spain, 8Hospital Universitario Reina Sofía, Córdoba, Spain, 9Complejo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Galicia, Spain, 10Hospital Universitario Son Llàtzer, Palma de Mallorca, Spain, 11Hospital Universitario de Salamanca, Salamanca, Spain, 12Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain, 13Parc Taulí Hospital Universitari. Institut d’Investigació i Innovació Parc Taulí I3PT, Sabadell, Spain, 14Complejo Hospitalario Universitario de A Coruña (CHUAC), A Coruña, Spain, 15Hospital Universitario Dr. Negrín, Las Palmas de Gran Canaria, Spain, 16Hospital Marina Baixa, Villajoyosa, 17Hospital de Sierrallana, Servicio de Reumatología, Torrelavega, Spain, 18Hospital Universitario Puerta de Hierro, Madrid, Spain, 19Hospital Universitario La Paz, Madrid, Spain

    Background/Purpose: Esperanza was a multicenter national health program developed to facilitate an early diagnosis of patients with Spondyloarthritis (SpA) in Spain. The main objective of…
  • Abstract Number: 1322 • ACR Convergence 2021

    Body Mass Index (BMI) Underestimates Obesity in Females with Axial Spondyloarthropathy

    Sinead Maguire1, Wilson Fiona2, Phil Gallagher3 and Finbar (Barry) O'Shea1, 1St James's Hospital, Dublin, Ireland, 2Discipline of Physiotherapy, Trinity College Dublin, Dublin, Ireland, 3St Vincent's Hospital, Dublin, Ireland

    Background/Purpose: Worldwide prevalence of obesity has been steadily increasing, despite public health campaigns to raise awareness. In axial spondyloarthropathy (axSpA) obesity has been shown to…
  • Abstract Number: 0383 • ACR Convergence 2021

    Differences Between Male vs. Female Presenting with Back Pain in an Integrated Delivery System

    Aniket Kawatkar1, Esther Yi2, Erika Estrada1, Jose Pio1, Cecilia Portugal1, David Yi1 and Steve Lee3, 1Kaiser Permanente Southern California, Pasadena, CA, 2Novartis Pharmaceuticals Corporation, Weehawken, NJ, 3Southern California Permanente Medical Group, Fontana, CA

    Background/Purpose: Back pain exerts significant economic burden and in its inflammatory form is the main clinical symptom of axial spondylarthritis. We evaluated differences in patient…
  • Abstract Number: 1550 • ACR Convergence 2021

    Flares and Side Effects After COVID-19 Vaccination in Patients with Rheumatic Diseases

    Anna Carbone, Gentiana Vukatana, Enrica Vandelli, Marica Trevisani, Elisa Rossi, Rita Mulè and Marco Fusconi, Rheumatology Unit, Azienda Ospedaliero-Universitaria Bologna, Bologna, Italy

    Background/Purpose: There is increasing interest in the safety of COVID-19 vaccination in patients with underlying chronic conditions. We investigated the rates of side effects and/or…
  • Abstract Number: 0450 • ACR Convergence 2021

    Identifying Trajectories of Radiographic Spinal Disease in Ankylosing Spondylitis

    Mark Hwang1, Minjae Lee2, Lianne Gensler3, Matthew Brown4, Amirali Tahanan5, Mohammad Rahbar6, Theresa Hunter7, Mingyan Shan8, Mariko Ishimori9, John Reveille10, Michael Weisman11 and Thomas Learch12, 1McGovern Medical School at the University of Texas Health Science Center at Houston, Houston, TX, 2UT Southwestern, Dallas, TX, 3Department of Rheumatology, University of California San Francisco, San Francisco, CA, 4King's College London, London, United Kingdom, 5McGovern Medical School, Houston, TX, 6Division of Clinical and Translational Sciences, Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, TX, 7Eli Lilly and Company, Indianapolis, IN, USA, Indianapolis, IN, 8Eli Lilly and Company, Indianapolis, IN, 9Cedars-Sinai Health System, Los Angeles, CA, 10Division of Rheumatology, The University of Texas Health Science Center at Houston, Houston, TX, 11Adjunct Professor of Medicine, Stanford University; Distinguished Professor of Medicine Emeritus, David Geffen School of Medicine at UCLA, Los Angeles, CA, 12Cedars-Sinai, Los Angeles, CA

    Background/Purpose: Little is known about the natural history of spinal disease in Ankylosing Spondylitis (AS). Our objective was to identify distinct patterns of change in…
  • « Previous Page
  • 1
  • …
  • 8
  • 9
  • 10
  • 11
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology